PLEASANTON — The Food and Drug Administration approved the Osteoboost belt in 2024, clearing the wearable device for treating osteopenia in post-menopausal women. The Osteoboost belt is the only vibration device that holds specific FDA authorization for this purpose.

The device delivers low-intensity mechanical vibrations directly to the spine and hips. These low-magnitude vibrations produce mechanical signals similar to muscle contractions, which stimulate osteoblasts, the cells responsible for building bone. Dr. Pamela Peeke, chief medical officer for Osteoboost, stated, "So for 30 minutes a day, when you wear the belt, you're stimulating those bone-building cells." Scientific research on vibration therapy originated from NASA-funded projects aimed at counteracting bone degradation in zero-gravity environments.

A randomized, double-blind, controlled trial evaluated the device. The study included 126 women aged 50 and older. Participants who used the device consistently showed reduced bone strength loss in the spinal region over a one-year period. Mike Jaasma, a founder of the company that produces the Osteoboost device, stated, "The placebo group lost 2.84% of their bone strength over the course of the year." He added, "Those who received the vibration therapy lost only 0.5%." The trial findings were published in the Journal of Bone and Mineral Research; however, the clinical study did not measure whether the device lowers the risk of bone fractures.

Medical professionals must prescribe the Osteoboost belt, which retails for approximately $1,000 paid directly by consumers. Health insurance providers do not reimburse patients for the device. Over-the-counter vibration plates are commercially available without prescriptions, but peer-reviewed evidence confirming their medical benefits remains limited. Dr. Eric Ascher, a primary care physician at Northwell Health, stated, "It might help, it can't hurt." Ascher stated that vibration therapy should supplement established bone-health routines such as weight-bearing exercise and nutritional intake. Ascher warns that individuals with blood clots, recent head trauma, or implanted pacemakers should not use vibration devices.